Jubilant Pharmova informs about composite scheme of arrangement

06 Feb 2021 Evaluate

Jubilant Pharmova has informed that the Board of Directors of the Company has, at its meeting held on Friday, February 5, 2021, considered and approved the following proposals: Appointment of Pramod Yadav as Non-executive Non-independent Director of the Company effective from February 5, 2021. Brief profile of Yadav is given as Annexure-A to this letter. Yadav is not related to any Director of the Company; and resignation of Rajesh Kumar Srivastava and Anant Pande as Director and Whole-time Director of the Company effective from the close of business hours of February 5, 2021. The above change in composition of the Board of Directors of the Company is on account of demerger of the Life Science Ingredients business of the Company into the Resulting Company, Jubilant Ingrevia, pursuant to the Composite Scheme of Arrangement.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

1034.90 -15.35 (-1.46%)
13-Jan-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1728.95
Dr. Reddys Lab 1190.35
Cipla 1448.15
Zydus Lifesciences 899.25
Lupin 2170.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×